Biotech News

Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026

ResMed (RMD)ResMedEarnings

Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2027 on Thursday, October 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.

Earnings webcast details:

Location: https://investor.resmed.com

Date: Thursday, October 29, 2026

Time: 1:30 p.m. PT / 4:30 p.m. ET

International: London, Thursday, October 29, 2026, 8:30 p.m. GMT

Sydney, Friday, October 30, 2026, 7:30 a.m. AEDT

Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.

A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from October 29, 2026, until November 12, 2026, at:

U.S.: +1 877.660.6853

International: +1 201.612.7415

Conference ID: 13762822

About Resmed Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.

Related news

ResMed

ResMed is a medical device and digital health company focused on sleep apnea, respiratory care, and related connected-health solutions. Its business is built around device usage, recurring supplies, and software-enabled care delivery.

Recent company news

Stock data

Close
220.69 USD
Market cap
26.52B USD
Exchange
NYSE
Sector
MedTech
Location
United States